Assess the risk for genetic predisposition towards cardiovascular diseases.
Cardiovascular Diseases (CVD) are often caused by a combination of a genetic predisposition and an unhealthy lifestyle. CVD StripAssays® and RealFast™ Assays identify various combinations of genetic CVD risk factors.
Cardiovascular Diseases (CVD)
- The two major manifestations of CVD are atherosclerosis and venous thrombosis.
- The risk for atherosclerosis is increased by the combination of an unhealthy lifestyle and variants of genes involved in endothelial dysfunction, hyperlipidemia, hypertension, and inflammation.
- Correspondingly, the interplay of adverse influences (female hormone intake, lack of physical activity, surgery, cancer) and certain genetic variants enhance the susceptibility to develop thrombosis.
- Testing for disease-associated genetic variants in conjunction with an adaptation of life style can greatly contribute to decrease an individual’s CVD risk.
Products
|
Name
|
REF
|
Unit Size
|
IFU
|
Brochure
|
|---|---|---|---|---|
|
FV-PTH-MTHFR StripAssay®
|
4-260
|
20 tests
|
||
|
Apo E StripAssay®
|
4-280
|
20 tests
|
||
|
FV-PTH StripAssay®
|
4-290
|
20 tests
|
||
|
CVD StripAssay® T
|
4-360
|
20 tests
|
||
|
CVD StripAssay® A
|
4-370
|
20 tests
|
||
|
FV Leiden RealFast™ Assay
|
7-110 7-113
|
100 rxn 32 rxn
|
|
|
|
FV-PTH mpx RealFast™ Assay
|
7-115 7-118
|
100 rxn 32 rxn
|
|
|
|
PTH 20210G>A RealFast™ Assay
|
7-120 7-123
|
100 rxn 32 rxn
|
|
|
|
MTHFR 677C>T RealFast™ Assay
|
7-160 7-163
|
100 rxn 32 rxn
|
|
|
|
MTHFR mpx RealFast™ Assay
|
7-165 7-168
|
100 rxn 32 rxn
|
|
|
|
MTHFR 1298A>C RealFast™ Assay
|
7-170 7-173
|
100 rxn 32 rxn
|
|
|
|
PAI-1 4G/5G RealFast™ Assay
|
7-180 7-183
|
100 rxn 32 rxn
|
|
|
|
FGB -455G>A RealFast™ Assay
|
7-230 7-233
|
100 rxn 32 rxn
|
|
|
|
FXII 46C>T RealFast™ Assay
|
7-240 7-243
|
100 rxn 32 rxn
|
|
|
|
FXIII V34L RealFast™ Assay
|
7-250 7-253
|
100 rxn 32 rxn
|
|